|
1）Fujita T, Henry W, Bartter F, et al. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med. 1980; 69: 334-44
|
|
|
|
2）Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997; 350: 1734-7
|
|
|
|
|
|
3）Guyton AC. Blood pressure control--special role of the kidneys and body fluids. Science. 1991; 252: 1813-6
|
|
|
|
|
|
4）Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep. 2011; 13: 55-66
|
|
|
|
|
|
5）Soundararajan R, Melters D, Shih IC, et al. Epithelial sodium channel regulated by differ-ential composition of a signaling complex. Proc Natl Acad Sci U S A. 2009; 106: 7804-9
|
|
|
|
|
|
6）Diakov A, Korbmacher C. A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channels alpha-subunit. J Biol Chem. 2004; 279: 38134-42
|
|
|
|
|
|
7）Thomas SV, Kathpalia PP, Rajagopal M, et al. Epithelial sodium channel regulation by cell surface-associated serum- and glucocorticoid-regulated kinase 1. J Biol Chem. 2011; 286: 32074-85
|
|
|
|
|
|
8）Ring AM, Cheng SX, Leng Q, et al. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo. Proc Natl Acad Sci U S A. 2007; 104: 4020-4
|
|
|
|
|
|
9）Pearce D, Kleyman TR. Salt, sodium channels, and SGK1. J Clin Invest. 2007; 117: 592-5
|
|
|
|
|
|
10）Zhang W, Xia X, Reisenauer MR, et al. Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel alpha. J Clin Invest. 2007; 117: 773-83
|
|
|
|
|
|
11）Soundararajan R, Pearce D, Ziera T. The role of the ENaC-regulatory complex in aldosterone-mediated sodium transport. Mol Cell Endocrinol. 2012; 350: 242-7
|
|
|
|
|
|
12）Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341: 709-17
|
|
|
|
|
|
13）Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003; 348: 1309-21
|
|
|
|
|
|
14）Zennaro MC, Souque A, Viengchareun S, et al. A new human MR splice variant is a ligand-independent transactivator modulating cortico-steroid action. Mol Endocrinol. 2001; 15: 1586-98
|
|
|
|
|
|
15）Mihailidou AS, Loan Le TY, Mardini M, et al. Glucocorticoids activate cardiac mineralocor-ticoid receptors during experimental myocardial infarction. Hypertension. 2009; 54: 1306-12
|
|
|
|
|
|
16）Wang H, Shimosawa T, Matsui H, et al. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J Hypertens. 2008; 26: 1453-62
|
|
|
|
|
|
17）Shibata S, Nagase M, Yoshida S, et al. Modification of mineralocorticoid receptor func-tion by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008; 14: 1370-6
|
|
|
|
|
|
18）Shibata S, Mu S, Kawarazaki H, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest. 2011; 121: 3233-43
|
|
|
|
|
|
19）Ono A, Kuwaki T, Kumada M, et al. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension. 1997; 29: 808-14
|
|
|
|
|
|
20）Fujita T, Sato Y. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension. 1992; 20: 466-72
|
|
|
|
|
|
21）Feng D, Yang C, Geurts AM, et al. Increased expression of NAD (P) H oxidase subunit p67 (phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab. 2012; 15: 201-8
|
|
|
|
|
|
22）Fujita M, Ando K, Kawarazaki H, et al. Sympa-thoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease. Hypertension. 2012; 59: 105-12
|
|
|
|
|
|
23）Symplicity HTN-2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376: 1903-9
|
|
|
|
|
|
24）Gurley SB, Riquier-Brison AD, Schnermann J, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011; 13: 469-75
|
|
|
|
|
|
25）Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001; 293: 1107-12
|
|
|
|
|
|
26）Mu S, Shimosawa T, Ogura S, et al. Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011; 17: 573-80
|
|
|
|
|